ACHN 975
Alternative Names: ACHN-975Latest Information Update: 16 Jul 2016
At a glance
- Originator Achaogen
- Class Antibacterials
- Mechanism of Action LpxC inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Pseudomonal infections
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for phase-I development in Pseudomonal-infections(In volunteers) in USA (IV)
- 18 Jul 2013 Achaogen terminates a phase I multiple-dose trial in healthy volunteers in USA (NCT01870245)
- 01 Jul 2013 Achaogen initiates enrolment in a phase I multiple-dose trial in healthy volunteers in USA (NCT01870245)